Six-Month Follow-Up Shows Reduced Stenosis, Healthy Endothelial Regrowth in Vessel Treated Proactively for Vulnerable Plaque DOYLESTOWN, Pa., June 1 (HSMN NewsFeed) — Six months after placement of a vProtect(TM) Luminal Shield to treat a "vulner…
Devices, Interventional Cardiology
Prescient Clinical, vProtect, Luminal Shield, vulnerable plaque, SECRITT I trial

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque”
Leave a Comment